Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
03/2012
03/08/2012US20120058938 Nutritional composition inducing a postprandial endocrine response
03/08/2012US20120058934 Treatment of diseases
03/08/2012US20120058207 Anti-diabetic nutraceutical composition from palm leaf extract
03/08/2012US20120058199 Compositions, use and method for the use of surface active proteins in topical drug delivery across keratin
03/08/2012US20120058193 Injectable smart gel and method for fabricating the same
03/08/2012US20120058186 Therapeutic or prophylactic agent for dyskinesia
03/08/2012US20120058185 Stable pharmaceutical compositions of olanzapine and process for their preparation
03/08/2012US20120058182 Method and composition for administering an nmda receptor antagonist to a subject
03/08/2012US20120058175 Transdermal Preparation
03/08/2012US20120058172 Plant extracts for use in brain modulation
03/08/2012US20120058160 Particulate materials
03/08/2012US20120058158 Sublingual Pharmaceutical Composition Comprising a Neutral Oil
03/08/2012US20120058137 Efficient transport into white blood cells
03/08/2012US20120058128 Anti- integrin antibodies, compositions, methods and uses
03/08/2012US20120058125 Methods relating to peripheral administration of nogo receptor polypeptides
03/08/2012US20120058123 N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors
03/08/2012US20120058119 Human tumor necrosis factor tr21 and methods based thereon
03/08/2012US20120058118 A-beta binding polypeptides
03/08/2012US20120058109 Reelin rescues cognitive function
03/08/2012US20120058107 Pyrrolo [3,2-c] pyridine-4-one 2-indolinone protein kinase inhibitors
03/08/2012US20120058102 Pharmacologically induced transgene ablation system
03/08/2012US20120058100 Modulation of drug release rate from electrospun fibers
03/08/2012US20120058099 Use of hypoxanthine for promotion of neuronal outgrowth
03/08/2012US20120058098 Non-cytotoxic protein conjugates
03/08/2012US20120058097 Compositions including a sodium channel blocker and a b vitamin molecule and methods of use thereof
03/08/2012US20120058091 Diagnostic and therapeutic treatments related to mitochondrial disorders
03/08/2012US20120058089 Treatment of organ injuries and burns using placental stem cells
03/08/2012US20120058088 Resveratrol-Containing Compositions And Methods Of Use
03/08/2012US20120058083 Therapies for Chronic Inflammatory Demyelinating Polyneuropathy Using Interferon-Beta
03/08/2012US20120058079 1,2,5-Oxadiazoles as Inhibitors of Indoleamine 2,3-Dioxygenase
03/08/2012US20120058055 Gastrorententive oral high dose zinc preparations
03/08/2012US20120058049 Cromolyn derivatives and related methods of imaging and treatment
03/08/2012DE102010062810A1 2-(R2-Thio)-10-[3-(4-R1-piperazin-1-yl)propyl]-10H-phenothiazine zur Behandlung neurodegenerativer Erkrankungen 2- (R2-thio) -10- [3- (4-R1-piperazin-1-yl) propyl] -10H-phenothiazine for the treatment of neurodegenerative diseases
03/08/2012CA2812970A1 Heterocyclyl compounds as histamine h3 receptor ligands
03/08/2012CA2810092A1 Deuterated analogs of pridopidine useful as dopaminergic stabilizers
03/08/2012CA2810071A1 Substituted tetrahydropyrrolopyrazine derivatives
03/08/2012CA2809779A1 Fused triazoles for the treatment or prophylaxis of mild cognitive impairment
03/08/2012CA2809774A1 Agonists of neurotrophin receptors and their use as medicaments
03/08/2012CA2809747A1 Compositions and methods for treating friedreich's ataxia with interferon gamma
03/08/2012CA2809112A1 Cyclic amide derivative
03/08/2012CA2807886A1 Substituted 1-oxo-dihydroisoquinoline-3-carboxamides as kcnq2/3 modulators
03/08/2012CA2806238A1 Methods for treating neurodegenerative diseases
03/08/2012CA2806103A1 Bicyclic oxazole and thiazole compounds and their use as allosteric modulators of mglur5 receptors
03/07/2012EP2426143A2 Method of providing disease-specific binding molecules and targets
03/07/2012EP2426125A1 1,4 disubstituted 3 cyano pyridone derivatives and their use as positive allosteric modulators of mGluR2 receptors
03/07/2012EP2426115A2 Alkynyl derivatives as modulators of metabotropic glutamate receptors
03/07/2012EP2426113A1 Carbinol compound having heterocyclic linker
03/07/2012EP2426112A1 4-[-2-[[5-methyl-1-(2-naphtalenyl)-1h-pyrazol-3-yl]oxy]ethyl]morpholine hydrochloride polymorphs and solvates
03/07/2012EP2426111A1 4-[-2-[[5-methyl-1-(2-naphtalenyl)-1h-pyrazol-3-yl]oxy]ethyl]morpholine hydrochloride amorphous solid forms
03/07/2012EP2425843A1 Dentine calcification agent and method for producing same
03/07/2012EP2425829A1 Soluble pharmaceutical forms of n,n'-diaminodiphenyl sulphone for optimum use in the treatment of various diseases
03/07/2012EP2425825A1 Pharmaceutical preparation containing oxycodone and naloxone
03/07/2012EP2425824A1 Pharmaceutical preparation containing oxycodone and naloxone
03/07/2012EP2425823A1 Pharmaceutical preparation containing oxycodone and naloxone
03/07/2012EP2425821A1 Pharmaceutical preparation containing oxycodone and naloxone
03/07/2012EP2425820A1 Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile
03/07/2012EP2425819A1 Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile
03/07/2012EP2424872A1 Neuroprotective compounds and their use
03/07/2012EP2424870A1 Therapeutic agents 713
03/07/2012EP2424869A1 5,6,7,8-TETRAHYDRO[1,2,4]TRIAZOLO[4,3-a]PYRAZINE DERIVATIVES AS P2X7 MODULATORS
03/07/2012EP2424866A1 Substituted imidazo[1,2-a]pyridine derivatives, pharmaceutical compositions, and methods of use as -secretase inhibitors
03/07/2012EP2424863A1 Isoxazole derivatives
03/07/2012EP2424861A1 Indole-2-carboxamide derivative
03/07/2012EP2424860A1 Heteroarylthiomethyl pyridine derivative
03/07/2012EP2424844A1 Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
03/07/2012EP2424552A2 Neuroprotective ganoderma compositions and methods of use
03/07/2012EP2424548A1 Use of n²o gas for treating chronic pain
03/07/2012EP2424539A1 Method of treatment of depression
03/07/2012EP2424535A2 Methods and compositions for treating dry eye
03/07/2012EP2424533A1 Substituted isoquinoline derivatives, pharmaceutical compositions, and methods of use as -secretase inhibitors
03/07/2012EP2424531A2 Irak kinase family as novel target and biomarker for alzheimer
03/07/2012EP2424522A1 Composition for removing atheromatous plaque
03/07/2012EP2424519A1 Use of pufas to treat nerve damage
03/07/2012EP2424514A1 Use of 1-phenyl-3-dimethylaminopropane compounds for treating rheumatoid pain
03/07/2012EP2424513A1 Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the treatment of primary progressive multiple sclerosis
03/07/2012EP2424498A1 Clavulanate formulation for neuroprotection and treatment of neurodegenerative disorders
03/07/2012EP2424495A1 Treatment of leber's hereditary optic neuropathy and dominant optic atrophy with tocotrienol quinones
03/07/2012EP2424494A1 Formulation of tocotrienol quinones for the treatment of ophthalmic diseases
03/07/2012EP2424366A1 Pyrido [4, 3-b]indoles and methods of use
03/07/2012EP2424364A1 Pyrido [4,3-b] indoles and methods of use
03/07/2012EP2424357A1 Treatment of neurodegeneration and neuroinflammation
03/07/2012EP2201002B1 5-ht7 receptor antagonists
03/07/2012EP2186830B1 Polyethylene glycol modified interferon alpha 2b and preparation method and applicatioins thereof
03/07/2012EP2137180B1 Dibenzo [b,f][1,4] oxazapine compounds
03/07/2012EP2100895B1 Tricyclic compound and medical use thereof
03/07/2012EP2079847B1 Use of lysozyme hydrolysates containing tryptophan
03/07/2012EP1727803B1 Processes for preparing substituted n-aryl-n'-[3-(1h-pyrazol-5-yl)phenyl] ureas and intermediates thereof
03/07/2012EP1663994B1 Tetrahydroquinazoline compounds as inhibitors of voltage-gated ion channels
03/07/2012EP1583506B1 Eye-drop vaccine containing copolymer 1 for therapeutic immunization
03/07/2012EP1519732B1 Use of vasopeptidase inhibitors in the treatment of nephropathy
03/07/2012EP1348029B1 Materials and methods relating to protein aggregation in neurodegenerative disease
03/07/2012EP1289540B1 Oncomodulin for treating neurological disorders
03/07/2012EP1255738B1 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
03/07/2012EP0885192B1 Dihydropyridine-, pyridine-, benzopyran- one- and triazoloquinazoline derivative, their preparation and their use as adenosine receptor antagonists
03/07/2012CN1861056B Slow-releasing preparation containing gastrodin
03/07/2012CN1549721B Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylation
03/07/2012CN102369202A Azaquinolinone derivatives and uses thereof
03/07/2012CN102369201A Bicyclic amide derivatives for the treatment of respiratory depression
03/07/2012CN102369200A Derivatives of azaspiranyl-alkylcarbamates of 5-member heterocyclic compounds, preparation thereof and therapeutic use thereof
03/07/2012CN102369196A Azetidines as histamine h3 receptor antagonists
1 ... 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 ... 1833